Geode Capital Management »

Candel Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.1M 449k 6.93
2024-06-30 $2.5M 398k 6.20
2024-03-31 $230k 146k 1.58
2023-09-30 $130k 139k 0.93
2023-06-30 $165k 131k 1.26
2023-03-31 $180k 131k 1.37
2022-12-31 $234k 131k 1.78
2022-09-30 $404k 129k 3.14
2022-06-30 $243k 75k 3.23
2022-03-31 $382k 75k 5.08
2021-12-31 $455k 58k 7.81
2021-09-30 $221k 20k 10.84